Literature DB >> 16482615

Causal role of Helicobacter pylori infection in gastric cancer.

Takafumi Ando, Yasuyuki Goto, Osamu Maeda, Osamu Watanabe, Kazuhiro Ishiguro, Hidemi Goto.   

Abstract

Gastric cancer is the second most frequent cancer in the world, accounting for a large proportion of all cancer cases in Asia, Latin America, and some countries in Europe. Helicobacter pylori (H pylori) is regarded as playing a specific role in the development of atrophic gastritis, which represents the most recognized pathway in multistep intestinal-type gastric carcinogenesis. Recent studies suggest that a combination of host genetic factors, bacterial virulence factors, and environmental and lifestyle factors determine the severity of gastric damage and the eventual clinical outcome of H pylori infection. The seminal discovery of H pylori as the leading cause of gastric cancer should lead to effective eradication strategies. Prevention of gastric cancer requires better screening strategies to identify candidates for eradication.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16482615      PMCID: PMC4066024          DOI: 10.3748/wjg.v12.i2.181

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  83 in total

1.  Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion.

Authors:  S Odenbreit; J Püls; B Sedlmaier; E Gerland; W Fischer; R Haas
Journal:  Science       Date:  2000-02-25       Impact factor: 47.728

Review 2.  Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group.

Authors: 
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

3.  Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation.

Authors:  M Stein; R Rappuoli; A Covacci
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

4.  Individual and joint contribution of family history and Helicobacter pylori infection to the risk of gastric carcinoma.

Authors:  H Brenner; V Arndt; T Stürmer; C Stegmaier; H Ziegler; G Dhom
Journal:  Cancer       Date:  2000-01-15       Impact factor: 6.860

5.  Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome.

Authors:  Carlo-F Zambon; Daniela Basso; Filippo Navaglia; Claudio Belluco; Alessandra Falda; Paola Fogar; Eliana Greco; Nicoletta Gallo; Massimo Rugge; Francesco Di Mario; Mario Plebani
Journal:  Cytokine       Date:  2004-12-08       Impact factor: 3.861

6.  Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori.

Authors:  E D Segal; J Cha; J Lo; S Falkow; L S Tompkins
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

7.  Serum antibodies against Helicobacter pylori proteins VacA and CagA are associated with increased risk for gastric adenocarcinoma.

Authors:  J Rudi; C Kolb; M Maiwald; I Zuna; A von Herbay; P R Galle; W Stremmel
Journal:  Dig Dis Sci       Date:  1997-08       Impact factor: 3.199

8.  Association between infections with CagA-positive or -negative strains of Helicobacter pylori and risk for gastric cancer in young adults. Research Group on Prevention of Gastric Carcinoma Among Young Adults.

Authors:  S Kikuchi; J E Crabtree; D Forman; M Kurosawa
Journal:  Am J Gastroenterol       Date:  1999-12       Impact factor: 10.864

9.  Association between serum pepsinogens and polymorphismof PTPN11 encoding SHP-2 among Helicobacter pylori seropositive Japanese.

Authors:  Yasuyuki Goto; Takafumi Ando; Kazuhito Yamamoto; Akiko Tamakoshi; Emad El-Omar; Hidemi Goto; Nobuyuki Hamajima
Journal:  Int J Cancer       Date:  2006-01-01       Impact factor: 7.396

10.  Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells.

Authors:  M Asahi; T Azuma; S Ito; Y Ito; H Suto; Y Nagai; M Tsubokawa; Y Tohyama; S Maeda; M Omata; T Suzuki; C Sasakawa
Journal:  J Exp Med       Date:  2000-02-21       Impact factor: 14.307

View more
  11 in total

1.  Cancer prevention from the perspective of global cancer burden patterns.

Authors:  Hiroki Nagai; Young Hak Kim
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

Review 2.  Helicobacter pylori and neurological diseases: Married by the laws of inflammation.

Authors:  Lourdes Alvarez-Arellano; Carmen Maldonado-Bernal
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

3.  Clinical implications and characteristics of factor forkhead box protein 3 in gastric cancer.

Authors:  Changli Jiang; Weihua Wang; Wei Yan; Yuhai Zhang; Jiangtao Yang; Song Zhang; Cun Zhang; Wei Zhang; Wei Han; Junzhi Wang; Ying-Qi Zhang
Journal:  Exp Ther Med       Date:  2011-05-12       Impact factor: 2.447

Review 4.  Hematologic manifestations of Helicobacter pylori infection.

Authors:  Germán Campuzano-Maya
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

5.  Association between the Dietary Inflammatory Index and Gastric Disease Risk: Findings from a Korean Population-Based Cohort Study.

Authors:  Sundara Raj Sreeja; Trong-Dat Le; Bang Wool Eom; Seung Hyun Oh; Nitin Shivappa; James R Hebert; Mi Kyung Kim
Journal:  Nutrients       Date:  2022-06-27       Impact factor: 6.706

Review 6.  [Medicinal prevention of gastrointestinal tumors: aspirin, Helicobacter and more?].

Authors:  J C Becker; W Domschke; T Pohle
Journal:  Internist (Berl)       Date:  2006-12       Impact factor: 0.743

7.  Frequency of Helicobacter pylori and CagA antibody in patients with gastric neoplasms and controls: the Indian enigma.

Authors:  Uday C Ghoshal; Shridhar Tiwari; Sadhna Dhingra; Rakesh Pandey; Ujjala Ghoshal; Shweta Tripathi; Himani Singh; V K Gupta; A K Nagpal; Sita Naik; Archana Ayyagari
Journal:  Dig Dis Sci       Date:  2008-03-20       Impact factor: 3.199

8.  Genomic methylation: a tool for typing Helicobacter pylori isolates.

Authors:  Filipa F Vale; Jorge M B Vítor
Journal:  Appl Environ Microbiol       Date:  2007-05-04       Impact factor: 4.792

9.  Anti-Helicobacter pylori activity of some newly synthesized derivatives of xanthone.

Authors:  Karolina Klesiewicz; Elżbieta Karczewska; Alicja Budak; Henryk Marona; Natalia Szkaradek
Journal:  J Antibiot (Tokyo)       Date:  2016-03-30       Impact factor: 2.649

10.  Nutrition deficiency increases the risk of stomach cancer mortality.

Authors:  Qing Da Li; Hao Li; Fu Ji Li; Mei Shu Wang; Zhuo Jian Li; Jing Han; Qing Hui Li; Xiang Ji Ma; Da Nan Wang
Journal:  BMC Cancer       Date:  2012-07-28       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.